Monogram Orthopaedics Inc... (MGRM)
Monogram Orthopaedics Statistics
Share Statistics
Monogram Orthopaedics has 35.29M shares outstanding. The number of shares has increased by 11.43% in one year.
| Shares Outstanding | 35.29M |
| Shares Change (YoY) | 11.43% |
| Shares Change (QoQ) | 2.85% |
| Owned by Institutions (%) | 4.46% |
| Shares Floating | 22.92M |
| Failed to Deliver (FTD) Shares | 1.13K |
| FTD / Avg. Volume | 0.17% |
Short Selling Information
The latest short interest is 508.58K, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 508.58K |
| Short % of Shares Out | 1.44% |
| Short % of Float | 1.84% |
| Short Ratio (days to cover) | 4.75 |
Valuation Ratios
The PE ratio is -4.73 and the forward PE ratio is -7.79. Monogram Orthopaedics's PEG ratio is 0.26.
| PE Ratio | -4.73 |
| Forward PE | -7.79 |
| PS Ratio | 0 |
| Forward PS | 0.7 |
| PB Ratio | 5.32 |
| P/FCF Ratio | -5.49 |
| PEG Ratio | 0.26 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Monogram Orthopaedics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.57, with a Debt / Equity ratio of 0.03.
| Current Ratio | 10.57 |
| Quick Ratio | 10.57 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.03 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-604.74K |
| Employee Count | 27 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 60% in the last 52 weeks. The beta is 0.77, so Monogram Orthopaedics's price volatility has been higher than the market average.
| Beta | 0.77 |
| 52-Week Price Change | 60% |
| 50-Day Moving Average | 2.66 |
| 200-Day Moving Average | 2.56 |
| Relative Strength Index (RSI) | 61 |
| Average Volume (20 Days) | 668.84K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -15.31M |
| Net Income | -16.33M |
| EBITDA | -15.31M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.5 |
Balance Sheet
The company has 15.66M in cash and 364K in debt, giving a net cash position of 15.29M.
| Cash & Cash Equivalents | 15.66M |
| Total Debt | 364K |
| Net Cash | 15.29M |
| Retained Earnings | -67.99M |
| Total Assets | 17.76M |
| Working Capital | 14.76M |
Cash Flow
In the last 12 months, operating cash flow was -13.97M and capital expenditures -84K, giving a free cash flow of -14.05M.
| Operating Cash Flow | -13.97M |
| Capital Expenditures | -84K |
| Free Cash Flow | -14.05M |
| FCF Per Share | -0.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MGRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MGRM is $5.4, which is 73.1% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.4 |
| Price Target Difference | 73.1% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 12.04 |
| Piotroski F-Score | 2 |